Indegene Limited — Updates, 11-07-2025: Press Release

Indegene has announced a board meeting to discuss the financial results for the quarter and half-year. The company launched NEXT Medical Writing Automation, a GenAI-powered platform designed to streamline complex medical writing workflows in life sciences. This tool integrates with existing systems, automates document drafting, and enhances compliance, enabling medical writers to focus on strategic tasks. The launch underscores Indegene’s push to modernize life sciences processes with AI-driven solutions, potentially improving operational efficiency and scalability in regulatory and clinical documentation.